News Sentiment

EYPT sentiment intelligence

Eyepoint Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 14.72 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+5.3% over one week, +13.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Two New EyePoint Employees Receive Options for 63,500 Shares

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction 5.3% Price confirming higher
Trend fit Trend inactive 13.0% over four weeks
Fair value 19.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 37
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingKey 7
Stock Titan 6
Investing.com 6
simplywall.st 6
GlobeNewswire 3
TradingView 3
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 12
Analyst action 6
Regulatory and legal 2
Guidance 1
Balance sheet 1
Macro sensitivity 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of EyePoint Pharmaceuticals Inc (EYPT), focusing on its price momentum, support and resistance levels, and key technical indicators. The stock currently has a price momentum score of 8.91 and is trading within a range suitable for swing

Tone
Positive 66/100
Event
Market update
Published
19 Jun 2026 06:41
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Valuation: PE, PB & Fair Value Analysis

EyePoint Pharmaceuticals Inc (EYPT) currently holds a valuation score of 6.48, placing it 149th out of 157 in the Pharmaceuticals industry. Its P/E ratio stands at -3.87, representing a significant variance from its recent highs and lows. The company has not yet disclosed relevan

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 19:39
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Institutional Confidence

EyePoint Pharmaceuticals Inc (EYPT) currently holds an institutional shareholding score of 10.00, placing it first among 157 companies in the Pharmaceuticals industry. The institutional shareholding proportion is 105.59%, which is a 16.25% decrease quarter-over-quarter. James Sim

Tone
Positive 61/100
Event
Market update
Published
18 Jun 2026 19:09
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 09:27
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for EyePoint Pharmaceuticals Inc (EYPT), detailing its business segments and regional contributions. As of April 6, the company's Q4 FY2022 revenue shows YUTIQ as a key product segment and the United States as the dominant regional contri

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 09:10
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Financial Health: Profitability & Balance Sheet Analysis

EyePoint Pharmaceuticals Inc (EYPT) currently holds a financial score of 5.96, ranking 149 out of 157 in the Pharmaceuticals industry, indicating stable financial status but low operating efficiency. The company's latest quarterly revenue decreased by 97.15% year-over-year to $69

Tone
Negative 39/100
Event
Earnings
Published
18 Jun 2026 06:41
Source
TradingKey
TradingKey Direct company coverage

EyePoint Pharmaceuticals Inc (EYPT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of EyePoint Pharmaceuticals Inc (EYPT) focusing on its dividend history and stock splits. It states that the company has not distributed any dividends over the past five years. The article also lists multiple stock merger events that occurred on

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 21:09
Source
TradingKey